US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biomarin Pharmaceutical

62.03

-0.6800-1.08%

Post-market: 62.030.00000.00%19:45 EDT

Volume:2.24M

Turnover:138.75M

Market Cap:11.89B

PE:28.10

High:65.40

Open:64.26

Low:60.92

Close:62.71

Loading ...

Overview Company News Filings

Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks

Teladoc Boosts Weight Care Access With LillyDirect, Aids Growth

INCY Opzelura Shows Superior Efficacy in 2 Prurigo Nodularis Studies

EC Approves Bristol Myers' Opdivo Plus Yervoy for First-Line HCC

LLY/INCY Olumiant Shows Superior Efficacy in Pediatric Alopecia Study

4 Discounted PEG Stocks Offering the Best Returns to Value Investors

Krystal Biotech Rises 15.8% in a Month: Should You Buy Now or Wait?

PSTV Stock Skyrockets on FDA's Orphan Drug Tag for Cancer Therapy

Scoop Up These 4 Stocks With Amazing Interest Coverage Ratio

Teladoc Health Enhances Prism Platform for Better Virtual Care

Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term

BioMarin Pharmaceutical (BMRN) Receives a Buy from TD Cowen

Statutory Profit Doesn't Reflect How Good BioMarin Pharmaceutical's (NASDAQ:BMRN) Earnings Are

Simply Wall St.

Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4

Regeneron Gets Positive CHMP Opinion for Multiple Myeloma Drug

KRYS Gets Positive CHMP Opinion for EU Approval of Skin Disease Drug

Is Auna S.A. (AUNA) Stock Outpacing Its Medical Peers This Year?

Novartis Gets CHMP Opinion for Label Expansion of Fabhalta

Kymera's Q4 Loss Wider Than Expected, Pipeline in Focus

BMRN or CSLLY: Which Is the Better Value Stock Right Now?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BMRN/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMRN\",,,,,undefined,":{"symbol":"BMRN","market":"US","secType":"STK","nameCN":"Biomarin Pharmaceutical","latestPrice":62.03,"timestamp":1746216000000,"preClose":62.71,"halted":0,"volume":2235183,"hourTrading":{"tag":"盘后","latestPrice":62.03,"preClose":62.03,"latestTime":"19:45 EDT","volume":51060,"amount":3167294.47,"timestamp":1746229536458},"delay":0,"floatShares":179589016,"shares":191754170,"eps":2.207261,"marketStatus":"Market Closed","change":-0.68,"latestTime":"05-02 16:00:00 EDT","open":64.255,"high":65.4,"low":60.92,"amount":138747426.802449,"amplitude":0.07144,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.207261,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":932702400000,"exchange":"NASDAQ","adjPreClose":62.71,"preHourTrading":{"tag":"盘前","latestPrice":64.59,"preClose":62.71,"latestTime":"09:28 EDT","volume":193,"amount":12463.418899999999,"timestamp":1746192480011},"postHourTrading":{"tag":"盘后","latestPrice":62.03,"preClose":62.03,"latestTime":"19:45 EDT","volume":51060,"amount":3167294.47,"timestamp":1746229536458},"volumeRatio":1.739742,"impliedVol":0.3123,"impliedVolPercentile":0.316},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMRN\",,,,,undefined,":{"symbol":"BMRN","floatShares":179589016,"roa":"5.15%","roe":"8.05%","lyrEps":2.246307,"volumeRatio":1.739742,"shares":191754170,"dividePrice":0,"high":65.4,"amplitude":0.07144,"preClose":62.71,"low":60.92,"week52Low":52.93,"pbRate":"2.10","psRate":"4.17","week52High":94.85,"institutionHeld":0.9275,"latestPrice":62.03,"eps":2.207261,"divideRate":0,"volume":2235183,"delay":0,"ttmEps":2.207261,"open":64.255,"prevYearClose":65.73,"prevWeekClose":63.3,"prevMonthClose":63.69,"prevQuarterClose":70.69,"fiveDayClose":63.3,"twentyDayClose":67.48,"sixtyDayClose":64.185},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMRN\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518719948","title":"Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2518719948","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518719948?lang=en_us&edition=fundamental","pubTime":"2025-03-11 17:03","pubTimestamp":1741683790,"startTime":"0","endTime":"0","summary":"As the craze of earnings season draws to a close, here’s a look back at some of the most exciting  results from Q4. Today, we are looking at therapeutics stocks, starting with Myriad Genetics .Over the next few years, therapeutic companies, which develop a wide variety of treatments for diseases and disorders, face strong tailwinds from advancements in precision medicine  and growing demand for treatments targeting rare diseases. However, headwinds such as rising scrutiny over drug pricing, regulatory unknowns, and competition from larger, more resourced pharmaceutical companies could weigh on growth.The 10 therapeutics stocks we track reported a satisfactory Q4. As a group, revenues beat analysts’ consensus estimates by 2.6%.Thankfully, share prices of the companies have been resilient as they are up 5.2% on average since the latest earnings results.Founded in 1991, Myriad Genetics  provides genetic testing and precision medicine solutions, with a focus on identifying hereditary risks","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/winners-losers-q4-myriad-genetics-090310721.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SQQQ","LU1066051498.USD","IE00B2B36J28.USD","QLD","LU0320765992.SGD","LU1732800096.USD","LU0198837287.USD","ABBV","LU0738911758.USD","GILD","MYGN","LU1989771016.USD","NVIW.SI","USJW.SI","LU1989763690.USD","MNQmain","IE00BGHQF631.EUR","IE0002141913.USD","LU0965508806.USD","LU1496350171.SGD","LU1037948897.HKD","BK4568","NQmain","IE00BZ1G4Q59.USD","LU0689472784.USD","LU1934455194.USD","LU0820561818.USD","LU1093756325.SGD","LENZ","TQQQ","LU0882574055.USD","BK4112","LU0170899867.USD","LU1267930490.SGD","LU1291159041.SGD","LU0661504455.SGD","ABT","LU2210150020.SGD","TSYW.SI","NDAQ","BK4139","QID","SG9999001440.SGD","USAW.SI","BMRN","LU0456855351.SGD","PSQ",".IXIC"],"gpt_icon":1},{"id":"2518042952","title":"Teladoc Boosts Weight Care Access With LillyDirect, Aids Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2518042952","media":"Zacks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518042952?lang=en_us&edition=fundamental","pubTime":"2025-03-11 02:11","pubTimestamp":1741630260,"startTime":"0","endTime":"0","summary":"Teladoc Health, Inc. TDOC recently announced that it is expanding access to clinically responsible weight management treatments by integrating with Eli Lilly’s LillyDirect pharmacy partner, Gifthealth. This strategic move is set to benefit Teladoc’s Comprehensive Weight Care, as it enhances accessibility to FDA-approved Zepbound for eligible members seeking effective weight management solutions.The integration will streamline the prescription, fulfillment, and delivery process for Teladoc’s members who are prescribed Zepbound for obesity. With direct access to LillyDirect, members without insurance coverage for GLP-1 medications can now receive affordable and reliable weight management treatments at home. This offering is expected to drive higher patient engagement and sustained outcomes, supporting Teladoc’s mission to deliver evidence-based and affordable care.By capitalizing on the growing demand for GLP-1 medications and offering end-to-end support for weight management, Teladoc is","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/teladoc-boosts-weight-care-access-181100483.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4534","BK4585","TDOC","BK4185","BK4548","BK4139","LU1861558580.USD","LU1861559042.SGD","BMRN","IE00B19Z3581.USD","IE00B7SZLL34.SGD","BK4504","LU2065731478.USD","OPCH","IE00B19Z3B42.SGD","BK4167","BK4566","BK4196","BK4567","ENSG","IE0002270589.USD","BK4588"],"gpt_icon":0},{"id":"2518565270","title":"INCY Opzelura Shows Superior Efficacy in 2 Prurigo Nodularis Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2518565270","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518565270?lang=en_us&edition=fundamental","pubTime":"2025-03-10 22:52","pubTimestamp":1741618320,"startTime":"0","endTime":"0","summary":"IncyteINCY announced positive results from two late-stage studies evaluating the safety and efficacy of its twice-daily ruxolitinib cream 1.5% in adults with prurigo nodularis . The data readout from both studies was recently presented at the 2025American Academy of Dermatology Annual Meeting.PN is a chronic inflammatory skin condition causing intense itching and thickened red nodules, primarily on the arms, legs, and trunk. Affecting around 200,000 people in the United States, it is most common in individuals aged 40-69. Persistent scratching leads to nodules, significantly impacting sleep and overall quality of life.Please note that ruxolitinib cream 1.5%, a topical JAK1/2 inhibitor, is currently approved in the United States under the brand name Opzelura for treating nonsegmental vitiligo in patients aged 12 and older. It is also approved for short-term and non-continuous chronictreatment of mild to moderate atopic dermatitis in non-immunocompromised patients of the same age group w","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/incy-opzelura-shows-superior-efficacy-145200413.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BMRN","LU0234570918.USD","LU2089984988.USD","LU0320765992.SGD","BK4532","LU0289739699.SGD","GILD","LU1559883803.SGD","BK4583","LU1430594728.SGD","BK4568","LU0109394709.USD","LU1839511570.USD","LU1066051498.USD","BK4007","INCY","CORT","LU2087621335.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","IE0002270589.USD","IE00B3T34201.USD","IE00B7SZLL34.SGD","BK4578","LU1585245621.USD","BK4588","BK4566","IE00BSNM7G36.USD","LU1066053197.SGD","LU0889565916.HKD","LU1571399168.USD","IE00B19Z3581.USD","BK4139","BK4585","IE00BKVL7J92.USD","LU2468319806.SGD","IE00B19Z3B42.SGD","LU0566484027.USD","PN","BK4550"],"gpt_icon":0},{"id":"2518277677","title":"EC Approves Bristol Myers' Opdivo Plus Yervoy for First-Line HCC","url":"https://stock-news.laohu8.com/highlight/detail?id=2518277677","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518277677?lang=en_us&edition=fundamental","pubTime":"2025-03-10 21:41","pubTimestamp":1741614060,"startTime":"0","endTime":"0","summary":"Bristol Myers BMY announced that the European Commission  has approved the blockbuster immuno-oncology drug Opdivo  plus Yervoy  for the first-line treatment of adult patients with unresectable or advanced hepatocellular carcinoma , a type of liver cancer.This approval is based on results of phase III CheckMate -9DW clinical study demonstrating a statistically significant and clinically meaningful improvement in overall survival with Opdivo plus Yervoy compared to investigator’s choice of Lenvima  or Nexavar .HCC accounts for 90% of liver cancer cases worldwide, which is the third most frequent cause of cancer death.In August 2024, the FDA also accepted BMY’s supplemental biologics license application  for Opdivo plus Yervoy as a potential first-line treatment option for adult patients with unresectable HCC and assigned a target action date of April 21, 2025.We note that the FDA granted accelerated approval in 2020 for the combination of Opdivo plus Yervoy as a second-line treatment fo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ec-approves-bristol-myers-opdivo-134100082.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4126","LU2089984988.USD","BK4532","EC","LU1670710588.SGD","LU1261432733.SGD","LU2242646821.SGD","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","LU2125154778.USD","GILD","IE00B2B36J28.USD","LU1032466523.USD","LU0882574055.USD","LU1093756168.USD","LU2468319806.SGD","BK4007","BMRN","LU0225771236.USD","BK4566","LU0321505868.SGD","LU1074936037.SGD","BK4559","HCC","MYE","LU0985481810.HKD","LU1868837300.USD","LU0109394709.USD","LU0320765992.SGD","BMY","LU0306807586.USD","IE00BZ1G4Q59.USD","BK4568","LU1323610961.USD","BK4139","LU0306806265.USD","LU0321505439.SGD","LU0889565916.HKD","LU0061475181.USD","LU0237698245.USD","IE0009355771.USD","LU0289739699.SGD","LU2360032135.SGD","LU1430594728.SGD","LU1868836914.USD","LU1868837136.USD","LU1670710661.SGD","LU1093756325.SGD","BK4578","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2518781082","title":"LLY/INCY Olumiant Shows Superior Efficacy in Pediatric Alopecia Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2518781082","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518781082?lang=en_us&edition=fundamental","pubTime":"2025-03-10 21:13","pubTimestamp":1741612380,"startTime":"0","endTime":"0","summary":"Eli LillyLLY and partner Incyte INCY announced that a late-stage study evaluating oral baricitinib in adolescent patients  with severe alopecia areata  showed clinically meaningful improvements in hair regrowth on the scalp, eyebrows and eyelashes at Week 36.The phase III BRAVE-AA-PEDS study enrolled 257 patients who were randomized to receive either a dose of baricitinib  or placebo.AA is an immune system disorder that leads to patchy hair loss on the scalp, face, and occasionally other parts of the body, with the potential to worsen over time. Around 40% of individuals with AA experience their first onset by the age of 20.LLY/INCY’s Phase III Alopecia Study Data in Detail. Lilly reported that 60% of patients receiving Olumiant 4 mg and 36.9% receiving Olumiant 2 mg experienced at least a 50% improvement in their condition, as measured by SALT score  compared to 5.7% on placebo. Additionally, 42.4% of patients receiving the 4 mg dose and 27.4% receiving the 2 mg dose achieved at least","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lly-incy-olumiant-shows-superior-131300949.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2361045086.USD","IE00B1BXHZ80.USD","LU2237443382.USD","LU0106261372.USD","IE00BFTCPJ56.SGD","LU1548497426.USD","LU0823416689.USD","IE0002270589.USD","LU0203201768.USD","LU1366192091.USD","LU2468319806.SGD","SGXZ31699556.SGD","LU0061475181.USD","LU0114720955.EUR","BK4599","LU1983299246.USD","BK4588","LU0320765992.SGD","SG9999018857.SGD","LU1720051017.SGD","BK4007","SG9999014914.USD","BK4578","IE00BSNM7G36.USD","LU2237443549.SGD","LU1551013342.USD","BMRN","LU2491050071.SGD","LLY","LU1069344957.HKD","GB00BDT5M118.USD","BK4566","INCY","LU0466842654.USD","LU1280957306.USD","LU2491050154.USD","BK4583","LU0109391861.USD","LU2237443978.SGD","SGXZ51526630.SGD","GILD","LU0820561818.USD","AA","LU1057294990.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU1430594728.SGD","BK4533","LU0354030511.USD","LU2089984988.USD"],"gpt_icon":1},{"id":"2518278158","title":"4 Discounted PEG Stocks Offering the Best Returns to Value Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2518278158","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518278158?lang=en_us&edition=fundamental","pubTime":"2025-03-10 20:44","pubTimestamp":1741610640,"startTime":"0","endTime":"0","summary":"With the market getting increasingly fickle on external shocks, investors are more focused on finding an investment strategy that emphasizes judging a stock's inherent potential. Needless to say, value investment is gaining popularity day by day. However, this apparently simple-to-understand investing strategy has historically shown dangerous outcomes a number of times because of people’s oversight of its basics.However, this simple value investment technique has some drawbacks, and not properly understanding the strategy may often lead to “value traps.” In such a situation, these value picks start to underperform over the long run when the temporary problems, which once drove the share price down, turn out to be persistent.However, for investors looking to escape such value traps, it is also vital to determine where the stock will be headed in the next 12 to 24 months. Warren Buffett advises these investors to focus on the earnings growth potential of a stock. This is where the import","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/4-discounted-peg-stocks-offering-124400327.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BD4GTW91.USD","LU0889565916.HKD","TAP","IE00BD4GTT62.SGD","LU0225771236.USD","LU0321505868.SGD","LU0109394709.USD","IE0002270589.USD","LU0320765992.SGD","IE00BD4GTV84.USD","BK4208","BK4211","BMRN","LU0256331488.USD","LU0306806265.USD","BK4139","JAZZ","LU0225284248.USD","BK4213","IE00BN0W2T93.GBP","BK4158","IE00BMG7P926.USD","IE00B19Z3581.USD","BK4566","LU2125154935.USD","IE00BMG7P694.USD","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","BK4585","LU0321505439.SGD","BK4533","BK4007","IE00BN0W2V16.EUR","LU2125154778.USD","DVN","PEG","BK4532","BK4588","IE00BMG7P819.SGD","LU0306807586.USD","ISBC","LU0823416689.USD","IE00BMG7P587.USD","LU2360032135.SGD","LU0985481810.HKD","IE00BN0W2W23.USD"],"gpt_icon":0},{"id":"2517448646","title":"Krystal Biotech Rises 15.8% in a Month: Should You Buy Now or Wait?","url":"https://stock-news.laohu8.com/highlight/detail?id=2517448646","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517448646?lang=en_us&edition=fundamental","pubTime":"2025-03-08 16:37","pubTimestamp":1741423020,"startTime":"0","endTime":"0","summary":"Shares of Krystal Biotech KRYS have gained 15.8% in the past month compared with the industry’s growth of 4%. The stock has also outperformed the industry and the sector in this timeframe.Last month, KRYS reported fourth-quarter 2024 results. While earnings beat estimates, sales missed the same. Nonetheless, shares surged post the quarterly release, mostly due to the strong uptake of Vyjuvek and encouraging pipeline progress.Krystal recorded Vyjuvek sales of $290.5 million, up from $50.7 million in 2023.It has made steady progress, securing access and reimbursement for Vyjuvek since its launch in the United States.As of February 2025, Krystal secured more than 510 reimbursement approvals for Vyjuvek in the United States and continues to maintain strong access nationwide, including positive access determinations for 97% of lives covered under commercial and Medicaid plans.Krystal is looking to get Vyjuvek approved in other geographies as well.In October, Krystal Biotech filed a new drug","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/krystal-biotech-rises-15-8-083700261.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1430594728.SGD","LU1066053197.SGD","LU1585245621.USD","LU1571399168.USD","BK4568","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU0234570918.USD","BK4139","LU1066051498.USD","BK4585","LU0109394709.USD","LU0320765992.SGD","LU2087621335.USD","BK4588","KRYS","IE00BZ1G4Q59.USD","IE00B7SZLL34.SGD","GILD","IE00BKVL7J92.USD","LU2468319806.SGD","LU0289739699.SGD","BK4578","IE00B19Z3581.USD","IE0002270589.USD","BK4566","BK4583","IE00B3T34201.USD","LU2089984988.USD","LU0058720904.USD","BK4550","LU1839511570.USD","LU0889565916.HKD","BMRN","BK4532"],"gpt_icon":0},{"id":"2517245951","title":"PSTV Stock Skyrockets on FDA's Orphan Drug Tag for Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2517245951","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517245951?lang=en_us&edition=fundamental","pubTime":"2025-03-07 23:58","pubTimestamp":1741363080,"startTime":"0","endTime":"0","summary":"Shares of Plus Therapeutics, Inc. PSTV were up a whopping 311.4% on March 6 after the company announced that the FDA has granted an Orphan Drug Designation  to its lead radiotherapeutic candidate, rhenium  obisbemeda, for treating leptomeningeal metastases  in patients with lung cancer. The stock continued to gain another 51.4% in after-hours trading following the news announcement.The FDA grants ODD to support the development of medicines for rare disorders that affect fewer than 200,000 people in the United States. The ODD makes the sponsor eligible to receive seven years of market exclusivity following a potential approval and tax credit for qualified clinical studies, as well as exemptions from certain FDA application fees, including the Prescription Drug User Fee Act  charge of $4.3 million in 2025.LM is a rare cancer complication in which the primary cancer spreads to the cerebrospinal fluid and leptomeninges that cover the brain and spinal cord.In the past year, shares of Plus T","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pstv-stock-skyrockets-fdas-orphan-155800501.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","PSTV","AMLX","IE00B19Z3B42.SGD","BMRN","BK4566","IE00B7SZLL34.SGD","XNCR","BK4007","IE00B19Z3581.USD","IE0002270589.USD"],"gpt_icon":1},{"id":"2517161326","title":"Scoop Up These 4 Stocks With Amazing Interest Coverage Ratio","url":"https://stock-news.laohu8.com/highlight/detail?id=2517161326","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517161326?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:55","pubTimestamp":1741269300,"startTime":"0","endTime":"0","summary":"Relying solely on stock price movements without understanding the company’s fundamentals can cause investors to lose money. Investors must carefully review a company's financial health to make informed decisions, especially in today’s unpredictable market.While sales and earnings are often the go-to metrics, they can sometimes be misleading and may not show whether a company has the financial strength to cover its obligations. This is where the coverage ratio holds the key — a higher ratio signals that a company is more capable of meeting its financial commitments.Boot Barn Holdings, Inc. BOOT, Sterling Infrastructure, Inc. STRL, Deckers Outdoor Corporation DECK and BioMarin Pharmaceutical Inc. BMRN have impressive interest coverage ratios.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/scoop-4-stocks-amazing-interest-135500715.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4094","BMRN","STRL","BK4585","IE00B7SZLL34.SGD","BK4139","BOOT","BK4146","LU0566484027.USD","DECK","EBIT","LU1559883803.SGD","LU2065731478.USD","BK4566","LU0266013472.USD","IE00B19Z3B42.SGD","BK4129","IE0002270589.USD","BK4567","IE00B19Z3581.USD","BK4588"],"gpt_icon":0},{"id":"2517925010","title":"Teladoc Health Enhances Prism Platform for Better Virtual Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2517925010","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517925010?lang=en_us&edition=fundamental","pubTime":"2025-03-06 02:00","pubTimestamp":1741197600,"startTime":"0","endTime":"0","summary":"Teladoc Health, Inc. TDOC recently introduced new enhancements to its proprietary care delivery platform, Prism. The platform has enabled the company to achieve a competitive edge due to its extensive reach and capability to provide a wide range of high-quality virtual healthcare services.As a result of the new advancements, the platform now features improved data integration and administrative tools that automatically identify and highlight recommended screenings and diagnostic assessments. This ensures that Teladoc Health’s care teams have access to key insights, enabling them to address health gaps more effectively during patient interactions. Additionally, clinicians and health coaches can now seamlessly access member eligibility information and refer patients to Teladoc Health’s Connected Care Partners.Another significant advancement is the expanded closed-loop referral functionality, which now allows Teladoc Health care teams to connect patients with in-network community care pro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/teladoc-health-enhances-prism-platform-180000924.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TDOC","LU2065731478.USD","BK4139","BK4567","LU1861559042.SGD","IE00B19Z3B42.SGD","IE0002270589.USD","BK4548","BMRN","IE00B19Z3581.USD","LU1861558580.USD","BK4504","BK4167","BK4534","IE00B7SZLL34.SGD","BK4196","ENSG","BK4566","OPCH","BK4585","BK4588","BK4185"],"gpt_icon":0},{"id":"2517302949","title":"Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term","url":"https://stock-news.laohu8.com/highlight/detail?id=2517302949","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517302949?lang=en_us&edition=fundamental","pubTime":"2025-03-05 22:40","pubTimestamp":1741185612,"startTime":"0","endTime":"0","summary":"Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike.While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics.Why Investors Should Pay Attention to This Value Stock. Finding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, and Price/Cash Flow to highlight the most attractive and discounted stocks.San Rafael, CA-based BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for life-threatening severe medical conditions, mainly for children.BioMarin Pharmaceutical Inc.  : Free Stock Analysis Report. This article originally published on Zacks Investment Re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-biomarin-pharmaceutical-bmrn-top-144012325.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B19Z3581.USD","BMRN","IE00B19Z3B42.SGD","BK4566","IE00B7SZLL34.SGD","BK4139","IE0002270589.USD"],"gpt_icon":0},{"id":"2517911295","title":"BioMarin Pharmaceutical (BMRN) Receives a Buy from TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2517911295","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517911295?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:18","pubTimestamp":1741180693,"startTime":"0","endTime":"0","summary":"In a report released today, Phil Nadeau from TD Cowen maintained a Buy rating on BioMarin Pharmaceutical (BMRN – Research Report), with a price tar...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/biomarin-pharmaceutical-bmrn-receives-a-buy-from-td-cowen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/biomarin-pharmaceutical-bmrn-receives-a-buy-from-td-cowen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4566","BK4127","IE0002270589.USD","IE00B19Z3581.USD","BMRN","BK4207","IE00B19Z3B42.SGD","COWN","IE00B7SZLL34.SGD","TD","BK4139"],"gpt_icon":0},{"id":"2516418676","title":"Statutory Profit Doesn't Reflect How Good BioMarin Pharmaceutical's (NASDAQ:BMRN) Earnings Are","url":"https://stock-news.laohu8.com/highlight/detail?id=2516418676","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516418676?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:59","pubTimestamp":1741093198,"startTime":"0","endTime":"0","summary":"BioMarin Pharmaceutical Inc.  just reported healthy earnings but the stock price didn't move much. Our analysis suggests that investors might be missing some promising details.Check out our latest analysis for BioMarin Pharmaceutical. NasdaqGS:BMRN Earnings and Revenue History March 4th 2025. To properly understand BioMarin Pharmaceutical's profit results, we need to consider the US$86m expense attributed to unusual items. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's hardly a surprise given these line items are considered unusual. Assuming those unusual expenses don't come up again, we'd therefore expect BioMarin Pharmaceutical to produce a higher profit next year, all else being equal.Because unusual items detracted from BioMarin Pharmaceutical's earnings over","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/statutory-profit-doesnt-reflect-good-125958453.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BMRN","NDAQ",".IXIC"],"gpt_icon":0},{"id":"2516249406","title":"Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4","url":"https://stock-news.laohu8.com/highlight/detail?id=2516249406","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516249406?lang=en_us&edition=fundamental","pubTime":"2025-03-04 17:03","pubTimestamp":1741078999,"startTime":"0","endTime":"0","summary":"As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, including Sarepta Therapeutics  and its peers.Over the next few years, therapeutic companies, which develop a wide variety of treatments for diseases and disorders, face strong tailwinds from advancements in precision medicine  and growing demand for treatments targeting rare diseases. However, headwinds such as rising scrutiny over drug pricing, regulatory unknowns, and competition from larger, more resourced pharmaceutical companies could weigh on growth.The 10 therapeutics stocks we track reported a satisfactory Q4. As a group, revenues beat analysts’ consensus estimates by 2.6%.In light of this news, share prices of the companies have held steady as they are up 1.3% on average since the latest earnings results.Founded in 1997, BioMarin Pharmaceutical  is a biopharmaceutical company specializing in developing and commercializing innovative therapies for rare genetic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/spotting-winners-sarepta-therapeutics-nasdaq-090319240.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0266013472.USD","ABBV","LU0689472784.USD","LU0128525929.USD","LU1291159041.SGD","MRNA","LU2089283258.USD","USJW.SI","LU0965508806.USD","QID","LU1093756325.SGD","LU0661504455.SGD","SG9999015986.USD","SRPT","QLD","BK4112","SG9999002232.USD","IE00BJJMRZ35.SGD","LU1037948897.HKD","BK4581","BK4551","PSQ","BK4534","TQQQ","BK4585","IE00B64PRP62.GBP","BMRN","NQmain","TSYW.SI","IE00B4R5TH58.HKD","LU1496350171.SGD","BK4548","SQQQ","MYGN",".IXIC","MNQmain","LU1003077747.HKD","LU1430594728.SGD","LU2210149790.SGD","SG9999004303.SGD","NVIW.SI","LU2210150020.SGD","LU2112291526.USD","NDAQ","ABT","LU0985320562.USD","USAW.SI","LU0203347892.USD","IE00BSNM7G36.USD"],"gpt_icon":1},{"id":"2516944666","title":"Regeneron Gets Positive CHMP Opinion for Multiple Myeloma Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2516944666","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516944666?lang=en_us&edition=fundamental","pubTime":"2025-03-04 04:00","pubTimestamp":1741032000,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals, Inc. REGN obtained positive opinion for its pipeline candidate linvoseltamab from the European Medicines Agency’s  Committee for Medicinal Products for Human Use .The CHMP recommended conditional marketing authorization of linvoseltamab to treat adults with relapsed and refractory (R/R) multiple myeloma . The recommendation is specific to those who have received at least three prior therapies, including a proteasome inhibitor, an immunomodulatory agent and an anti-CD38 monoclonal antibody, and have demonstrated disease progression on the last therapy.A final decision is expected in the coming months.Regeneron’s shares have lost 30.5% in the past year compared with the medical-biomedical genetics industry’s decline of 6.7%.Regeneron Pharmaceuticals Stock Price, Consensus and EPS Surprise. Regeneron Pharmaceuticals, Inc. price-consensus-eps-surprise-chart | Regeneron Pharmaceuticals, Inc. Quote. REGN’s oncology franchise got a boost with the European Commission","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/regeneron-gets-positive-chmp-opinion-200000419.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0053666078.USD","LU0234570918.USD","LU0114720955.EUR","BK4139","BK4007","IE00BSNM7G36.USD","LU0289739699.SGD","LU1917777945.USD","BK4568","LU1839511570.USD","LU0823416689.USD","LU1585245621.USD","RHHBY","LU1974910355.USD","IE00B19Z3B42.SGD","IE0002270589.USD","IE00B19Z3581.USD","LU0058720904.USD","LU2237438978.USD","03165","BK4087","BK4550","IE00B7SZLL34.SGD","IE00B3T34201.USD","BK4585","LU2362541513.USD","BK4566","REGN","LU2023250504.SGD","LU0889565916.HKD","BMRN","BK4532","BK4094","GILD","BK4583","LU1066051498.USD","LU0882574055.USD","FL","LU2362540622.SGD","LU0109394709.USD","LU1066053197.SGD","LU1430594728.SGD","IE00BZ1G4Q59.USD","CHMP","LU2087621335.USD","LU2468319806.SGD","IE00BKVL7J92.USD","LU0320765992.SGD","LU2106854487.HKD","LU2089984988.USD"],"gpt_icon":0},{"id":"2516656745","title":"KRYS Gets Positive CHMP Opinion for EU Approval of Skin Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2516656745","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516656745?lang=en_us&edition=fundamental","pubTime":"2025-03-03 23:59","pubTimestamp":1741017540,"startTime":"0","endTime":"0","summary":"Krystal BiotechKRYS announced that the European Medicines Agency'sCommittee for Medicinal Products for Human Use  has adopted a positive opinion recommending the approval of Vyjuvek for the treatment of wounds in patients with dystrophic epidermolysis bullosa . The intended DEB patient population includes those who have mutations in the COL7A1 gene starting from birth.DEB is a rare and severe monogenic disease that affects the skin and mucosal tissues. It is caused by one or more mutations in a gene called COL7A1. Vyjuvekis a non-invasive, topical, redosable gene therapy designed to deliver two copies of theCOL7A1 gene when applied directly to DEB wounds.In the past three months, shares of Krystal Biotech have plunged 18.3% compared with the industry’s 0.6% decline.More on CHMP’s Positive Opinion on Vyjuvek’s EU Approval. The positive CHMP opinion recommending the approval of Vyjuvekfor the DEB indication in the EU is based on the results of Krystal Biotech’s phase I/II GEM-1 and phase","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/krys-gets-positive-chmp-opinion-155900015.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4583","LU0320765992.SGD","IE00B19Z3581.USD","BK4588","IE00BKVL7J92.USD","IE00B7SZLL34.SGD","LU2065170008.USD","LU0109394709.USD","BK4139","BK4578","BK4156","BK4566","IE0002270589.USD","IE00B19Z3B42.SGD","BK4550","KRYS","LU0234570918.USD","LU2087621335.USD","IE00BZ1G4Q59.USD","LU1066051498.USD","LU1571399168.USD","LU0058720904.USD","LU2065171311.SGD","IE00BSNM7G36.USD","LU1839511570.USD","BK4087","BK4585","BK4532","LU0289739699.SGD","BMRN","LU0889565916.HKD","GILD","IE00B3T34201.USD","LU2065169927.USD","LU2089984988.USD","LU2468319806.SGD","LU1585245621.USD","BK4568","FOLD","LU1430594728.SGD","LU2065171402.SGD","CHMP","LU1066053197.SGD"],"gpt_icon":0},{"id":"2516927653","title":"Is Auna S.A. (AUNA) Stock Outpacing Its Medical Peers This Year?","url":"https://stock-news.laohu8.com/highlight/detail?id=2516927653","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516927653?lang=en_us&edition=fundamental","pubTime":"2025-03-03 22:40","pubTimestamp":1741012809,"startTime":"0","endTime":"0","summary":"The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Auna S.A.  is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole?By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.Auna S.A. is one of 1012 companies in the Medical group. The Medical group currently sits at #4 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Auna S.A. is currently","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/auna-auna-stock-outpacing-medical-144009399.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B7SZLL34.SGD","IE0002270589.USD","IE00B19Z3B42.SGD","AUNA","IE00B19Z3581.USD","BK4139","BK4566","BMRN","BK4185"],"gpt_icon":0},{"id":"2516653171","title":"Novartis Gets CHMP Opinion for Label Expansion of Fabhalta","url":"https://stock-news.laohu8.com/highlight/detail?id=2516653171","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516653171?lang=en_us&edition=fundamental","pubTime":"2025-03-03 22:39","pubTimestamp":1741012740,"startTime":"0","endTime":"0","summary":"Novartis NVS announced that the Committee for Medicinal Products for Human Use  of the European Medicines Agency has adopted a positive opinion for the label expansion of Fabhalta ((iptacopan).Fabhalta is an oral, Factor B inhibitor of the alternative complement pathway 6-7.The CHMP recommended granting a marketing authorization to Fabhalta for the treatment of adults with C3 glomerulopathy , an ultra-rare, progressive kidney disease with no currently approved treatments.A final decision from the European Commission  is expected in two months.The CHMP’s positive opinion is based on robust data from APPEAR-C3G, a randomized placebo-controlled phase III study. The study showed patients treated with Fabhalta, in addition to supportive care, achieved a statistically significant and clinically meaningful 35.1% reduction in proteinuria  at 6 months when compared to placebo.A potential approval will make Fabhalta the only drug indicated to target the underlying cause of C3G.Shares of Novartis","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novartis-gets-chmp-opinion-label-143900090.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4532","EC","LU0289739699.SGD","LU2089984988.USD","IE00B7SZLL34.SGD","BK4087","BK4139","LU1066053197.SGD","BMRN","LU1430594728.SGD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","BK4568","IE00BKVL7J92.USD","NVS","IE00BSNM7G36.USD","IE00BFTCPJ56.SGD","LU1839511570.USD","BK4583","IE00B19Z3B42.SGD","IE0009355771.USD","LU1571399168.USD","LU0889565916.HKD","LU1585245621.USD","BK4585","LU0211331839.USD","LU0234570918.USD","IE00BJJMRZ35.SGD","IE00BZ1G4Q59.USD","IE00B3T34201.USD","IE0002270589.USD","BK4007","LU1066051498.USD","LU0320765992.SGD","BK4201","LU2087621335.USD","BK4578","BK4588","IE00BJT1NW94.SGD","BK4566","LU0109394709.USD","GILD","IE00B19Z3581.USD","BK4550","IE0002141913.USD","LU0058720904.USD","LU2468319806.SGD","CHMP"],"gpt_icon":0},{"id":"2516130552","title":"Kymera's Q4 Loss Wider Than Expected, Pipeline in Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2516130552","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516130552?lang=en_us&edition=fundamental","pubTime":"2025-03-01 02:12","pubTimestamp":1740766320,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics, Inc. KYMR reported a fourth-quarter 2024 loss of 88 cents per share, wider than the Zacks Consensus Estimate of a loss of 76 cents. In the year-ago quarter, Kymera reported a loss of 25 cents per share.The year-over-year deterioration was due to lower collaboration revenues and higher operating expenses.Collaboration revenues totaled $7.4 million, which missed the Zacks Consensus Estimate of $13 million.In the year-ago quarter, Kymera earned collaboration revenues of $47.9 million due to the recognition of milestone payments related to the advancement of KT-474 into phase II testing under its collaboration with pharma bigwig Sanofi SNY.Shares of KYMR have lost 30.1% year to date compared with the industry’s decline of 8%.In October, Kymera initiated the phase I study on KT-621 in healthy volunteers. KT-621 is an investigational, first-in-class, once daily, oral degrader of STAT6.Kymera intends to advance KT-295, an investigational, first-in-class, once daily, oral ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kymeras-q4-loss-wider-expected-181200761.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4550","BK4566","IE00B3T34201.USD","LU2087621335.USD","KYMR","IE00BFXG1179.USD","LU0289739699.SGD","BK4568","IE00B7SZLL34.SGD","BK4532","BK4578","BK4588","LU0320765992.SGD","IE00BKVL7J92.USD","BK4585","IE00BZ1G4Q59.USD","LU0234570918.USD","BK4583","IE00BSNM7G36.USD","LU1430594728.SGD","IE0002270589.USD","LU1839511570.USD","LU1585245621.USD","LU2468319806.SGD","LU0889565916.HKD","LU1571399168.USD","IE00B19Z3B42.SGD","LU2089984988.USD","GILD","BK4139","LU0058720904.USD","BMRN","IE00B19Z3581.USD","LU1066053197.SGD","BK4007","LU1066051498.USD","LU0109394709.USD","SNY"],"gpt_icon":0},{"id":"2516308887","title":"BMRN or CSLLY: Which Is the Better Value Stock Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2516308887","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516308887?lang=en_us&edition=fundamental","pubTime":"2025-03-01 00:40","pubTimestamp":1740760814,"startTime":"0","endTime":"0","summary":"Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both BioMarin Pharmaceutical  and CSL Limited Sponsored ADR . But which of these two stocks offers value investors a better bang for their buck right now?The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to identify stocks with specific traits.Currently, BioMarin Pharmaceutical has a Zacks Rank of #2 , while CSL Limited Sponsored ADR has a Zacks Rank of #4 . Investors should feel comfortable knowing that BMRN likely has seen a stronger improvement to its earnings outlook than CSLLY has recently. But this is just one piece of the puzzle for value investors.BioMarin Pharmaceutical Inc.  : Free Stock Analysis Report. CSL Limited Sponsored ADR  : Free Stock Analysis Report. This article orig","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bmrn-cslly-better-value-stock-164014485.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0002270589.USD","BK4566","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","IE00B19Z3581.USD","CSL.AU","BMRN","CSLLY","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMRN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-01","symbol":"BMRN","fiscalQuarterEnding":"2025/03","expectedEps":0.73,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746072000000,"reportTimeType":"post","actualEps":0.98},{"market":"US","date":"2025-02-19","symbol":"BMRN","fiscalQuarterEnding":"2024/12","expectedEps":0.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739941200000,"reportTimeType":"post","actualEps":0.72},{"market":"US","date":"2024-10-29","symbol":"BMRN","fiscalQuarterEnding":"2024/09","expectedEps":0.57,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730174400000,"reportTimeType":"post","actualEps":0.74},{"market":"US","date":"2024-08-05","symbol":"BMRN","fiscalQuarterEnding":"2024/06","expectedEps":0.38,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722830400000,"reportTimeType":"post","actualEps":0.77},{"market":"US","date":"2024-04-24","symbol":"BMRN","fiscalQuarterEnding":"2024/03","expectedEps":0.37,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1713931200000,"reportTimeType":"post","actualEps":0.49}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMRN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMRN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3448,"buy":0.4483,"hold":0.2069,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4483,"analysts":29,"updateTime":1740456000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BMRN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BMRN","date":"2025-05-01","current":28.610907,"percent":0.249796,"low":-246.955768,"twenty":18.510369,"median":112.838199,"eighty":244.603325,"high":1069.125802,"avg":172.218239,"sd":250.33871,"marketCap":12212823087},"quantilePoints":[{"date":"2020-05-08","current":151.00669,"twenty":-146.720429,"median":-112.32011,"eighty":-70.459717,"marketCap":17215668691},{"date":"2020-05-15","current":148.690831,"twenty":-146.720429,"median":-112.264026,"eighty":-67.95747,"marketCap":16951646881},{"date":"2020-05-22","current":154.670823,"twenty":-146.720429,"median":-112.009509,"eighty":-65.875106,"marketCap":17633401828},{"date":"2020-05-29","current":169.010114,"twenty":-146.720429,"median":-111.583861,"eighty":-65.266721,"marketCap":19268167006},{"date":"2020-06-05","current":167.82046,"twenty":-146.720429,"median":-111.430067,"eighty":-53.616205,"marketCap":19132539364},{"date":"2020-06-12","current":167.693564,"twenty":-146.720429,"median":-111.166002,"eighty":-52.32921,"marketCap":19118072416},{"date":"2020-06-19","current":196.879731,"twenty":-146.720429,"median":-110.643992,"eighty":-51.800638,"marketCap":22445470566},{"date":"2020-06-26","current":196.72111,"twenty":-146.720429,"median":-110.454206,"eighty":-51.112661,"marketCap":22427386881},{"date":"2020-07-02","current":201.099035,"twenty":-146.720429,"median":-110.047751,"eighty":-50.787838,"marketCap":22926496603},{"date":"2020-07-10","current":199.956968,"twenty":-146.720429,"median":-109.640088,"eighty":-50.663322,"marketCap":22796294067},{"date":"2020-07-17","current":203.367308,"twenty":-146.720429,"median":-109.199968,"eighty":-50.401769,"marketCap":23185093307},{"date":"2020-07-24","current":195.023871,"twenty":-146.720429,"median":-109.08296,"eighty":-50.291122,"marketCap":22233891445},{"date":"2020-07-31","current":190.043188,"twenty":-146.720429,"median":-108.761911,"eighty":-50.018415,"marketCap":21666063717},{"date":"2020-08-07","current":176.02739,"twenty":-146.720429,"median":-108.266562,"eighty":-49.711244,"marketCap":21520756675},{"date":"2020-08-14","current":175.270889,"twenty":-146.720429,"median":-107.874867,"eighty":-49.409876,"marketCap":21428268381},{"date":"2020-08-21","current":111.294641,"twenty":-146.720429,"median":-107.54787,"eighty":-49.282149,"marketCap":13606660262},{"date":"2020-08-28","current":113.297144,"twenty":-146.720429,"median":-107.159772,"eighty":-49.094704,"marketCap":13851482218},{"date":"2020-09-04","current":112.733477,"twenty":-146.720429,"median":-106.448863,"eighty":-48.818303,"marketCap":13782569372},{"date":"2020-09-11","current":106.874302,"twenty":-146.720429,"median":-105.912505,"eighty":-48.569168,"marketCap":13066238463},{"date":"2020-09-18","current":117.74715,"twenty":-146.720429,"median":-105.43525,"eighty":-48.312221,"marketCap":14395531009},{"date":"2020-09-25","current":114.795312,"twenty":-146.720429,"median":-104.968329,"eighty":-48.052471,"marketCap":14034645311},{"date":"2020-10-02","current":111.220475,"twenty":-146.720429,"median":-104.968329,"eighty":-47.767481,"marketCap":13597592783},{"date":"2020-10-09","current":116.960982,"twenty":-146.720429,"median":-104.968329,"eighty":-47.469759,"marketCap":14299415723},{"date":"2020-10-16","current":117.554316,"twenty":-146.720429,"median":-104.968329,"eighty":-47.31175,"marketCap":14371955562},{"date":"2020-10-23","current":115.002979,"twenty":-146.720429,"median":-104.968329,"eighty":-47.07446,"marketCap":14060034255},{"date":"2020-10-30","current":110.40464,"twenty":-146.720429,"median":-104.968329,"eighty":-46.453512,"marketCap":13497850504},{"date":"2020-11-06","current":16.333756,"twenty":-145.315182,"median":-104.024299,"eighty":-46.24616,"marketCap":13916768073},{"date":"2020-11-13","current":16.516158,"twenty":-144.868574,"median":-103.498065,"eighty":-45.910184,"marketCap":14072179785},{"date":"2020-11-20","current":16.181659,"twenty":-144.868574,"median":-102.889101,"eighty":-45.353548,"marketCap":13787178208},{"date":"2020-11-27","current":17.129762,"twenty":-144.868574,"median":-102.47937,"eighty":-34.458654,"marketCap":14594985226},{"date":"2020-12-04","current":16.961447,"twenty":-144.868574,"median":-101.666821,"eighty":-33.817892,"marketCap":14451576789},{"date":"2020-12-11","current":16.93588,"twenty":-144.868574,"median":-101.332926,"eighty":-32.987662,"marketCap":14429793229},{"date":"2020-12-18","current":18.930091,"twenty":-144.868574,"median":-100.855221,"eighty":-31.786506,"marketCap":16128910912},{"date":"2020-12-24","current":18.88961,"twenty":-144.868574,"median":-100.530187,"eighty":-31.699842,"marketCap":16094420276},{"date":"2020-12-31","current":18.682945,"twenty":-144.868574,"median":-100.130791,"eighty":-31.545183,"marketCap":15918336499},{"date":"2021-01-08","current":19.145278,"twenty":-144.868574,"median":-99.499409,"eighty":-31.239921,"marketCap":16312255876},{"date":"2021-01-15","current":17.677318,"twenty":-144.868574,"median":-99.011614,"eighty":-31.142754,"marketCap":15061516470},{"date":"2021-01-22","current":18.746862,"twenty":-144.868574,"median":-98.307572,"eighty":-30.998361,"marketCap":15972795399},{"date":"2021-01-29","current":17.636837,"twenty":-144.868574,"median":-97.576033,"eighty":-30.940261,"marketCap":15027025834},{"date":"2021-02-05","current":18.156695,"twenty":-144.868574,"median":-97.576033,"eighty":-30.85726,"marketCap":15469958221},{"date":"2021-02-12","current":18.544458,"twenty":-144.868574,"median":-97.576033,"eighty":-30.741472,"marketCap":15800342215},{"date":"2021-02-19","current":17.419519,"twenty":-144.868574,"median":-97.521381,"eighty":-30.612592,"marketCap":14841865573},{"date":"2021-02-26","current":16.477433,"twenty":-144.868574,"median":-95.195111,"eighty":-30.351921,"marketCap":14072205552},{"date":"2021-03-05","current":16.549346,"twenty":-144.931156,"median":-92.988484,"eighty":-30.193594,"marketCap":14133621026},{"date":"2021-03-12","current":16.344954,"twenty":-144.931156,"median":-92.037344,"eighty":-30.118727,"marketCap":13959064533},{"date":"2021-03-19","current":16.645154,"twenty":-144.931156,"median":-90.941505,"eighty":-29.706846,"marketCap":14215444382},{"date":"2021-03-26","current":16.070302,"twenty":-144.868574,"median":-89.639785,"eighty":-29.214173,"marketCap":13724504246},{"date":"2021-04-01","current":16.570636,"twenty":-144.868574,"median":-88.5032,"eighty":-28.439397,"marketCap":14151803994},{"date":"2021-04-09","current":16.408826,"twenty":-144.931156,"median":-87.602744,"eighty":-27.75353,"marketCap":14013613437},{"date":"2021-04-16","current":16.904902,"twenty":-144.931156,"median":-86.817737,"eighty":-27.498326,"marketCap":14437276592},{"date":"2021-04-23","current":16.838842,"twenty":-144.931156,"median":-86.272203,"eighty":-27.151224,"marketCap":14380859669},{"date":"2021-04-30","current":17.900998,"twenty":-144.931156,"median":-85.694758,"eighty":15.913176,"marketCap":14232904679},{"date":"2021-05-07","current":17.874568,"twenty":-144.931156,"median":-85.610935,"eighty":16.023777,"marketCap":14211889902},{"date":"2021-05-14","current":17.681503,"twenty":-144.931156,"median":-85.219763,"eighty":16.210666,"marketCap":14058386140},{"date":"2021-05-21","current":17.950414,"twenty":-144.931156,"median":-84.959558,"eighty":16.297129,"marketCap":14272194951},{"date":"2021-05-28","current":17.766543,"twenty":-144.931156,"median":-84.679572,"eighty":16.395247,"marketCap":14126000892},{"date":"2021-06-04","current":17.902148,"twenty":-144.931156,"median":-84.297713,"eighty":16.432736,"marketCap":14233819010},{"date":"2021-06-11","current":18.862875,"twenty":-144.931156,"median":-84.279085,"eighty":16.501579,"marketCap":14997682966},{"date":"2021-06-18","current":18.823802,"twenty":-144.931156,"median":-84.279085,"eighty":16.577449,"marketCap":14966616728},{"date":"2021-06-25","current":19.488036,"twenty":-144.931156,"median":-84.279085,"eighty":16.648523,"marketCap":15494742764},{"date":"2021-07-02","current":19.644327,"twenty":-144.931156,"median":-84.279085,"eighty":16.690717,"marketCap":15619007714},{"date":"2021-07-09","current":19.219125,"twenty":-144.931156,"median":-84.185949,"eighty":16.765656,"marketCap":15280933954},{"date":"2021-07-16","current":18.120495,"twenty":-144.931156,"median":-83.841344,"eighty":16.854046,"marketCap":14407424455},{"date":"2021-07-23","current":17.706785,"twenty":-144.931156,"median":-83.683013,"eighty":16.951792,"marketCap":14078487823},{"date":"2021-07-30","current":16.8013,"twenty":-144.931156,"median":-83.422231,"eighty":17.027349,"marketCap":14066283248},{"date":"2021-08-06","current":17.110693,"twenty":-144.931156,"median":-82.965863,"eighty":17.063524,"marketCap":14325311683},{"date":"2021-08-13","current":16.431784,"twenty":-144.931156,"median":-82.965863,"eighty":17.063524,"marketCap":13756919692},{"date":"2021-08-20","current":16.455874,"twenty":-144.931156,"median":-82.965863,"eighty":17.063524,"marketCap":13777088440},{"date":"2021-08-27","current":18.288928,"twenty":-144.931156,"median":-82.965863,"eighty":17.151762,"marketCap":15311746815},{"date":"2021-09-03","current":18.604292,"twenty":-144.931156,"median":-82.965863,"eighty":17.265235,"marketCap":15575774062},{"date":"2021-09-10","current":17.077843,"twenty":-144.931156,"median":-82.965863,"eighty":17.275493,"marketCap":14297808844},{"date":"2021-09-17","current":17.029662,"twenty":-144.931156,"median":-82.965863,"eighty":17.275493,"marketCap":14257471348},{"date":"2021-09-24","current":17.213624,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":14411487243},{"date":"2021-10-01","current":16.89826,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":14147459995},{"date":"2021-10-08","current":17.044992,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":14270306006},{"date":"2021-10-15","current":16.620127,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":13914602631},{"date":"2021-10-22","current":16.14927,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":13520395283},{"date":"2021-10-29","current":913.742979,"twenty":-144.931156,"median":-82.965863,"eighty":17.356508,"marketCap":14544047003},{"date":"2021-11-05","current":967.9689,"twenty":-144.931156,"median":-82.965863,"eighty":17.405709,"marketCap":15407160981},{"date":"2021-11-12","current":942.70851,"twenty":-144.931156,"median":-82.965863,"eighty":17.560148,"marketCap":15005091360},{"date":"2021-11-19","current":1055.053805,"twenty":-144.931156,"median":-82.965863,"eighty":17.678992,"marketCap":16793291407},{"date":"2021-11-26","current":1010.184893,"twenty":-144.931156,"median":-82.965863,"eighty":17.719077,"marketCap":16079112949},{"date":"2021-12-03","current":956.780508,"twenty":-144.931156,"median":-82.965863,"eighty":17.763785,"marketCap":15229075350},{"date":"2021-12-10","current":979.157292,"twenty":-144.931156,"median":-82.965863,"eighty":17.780334,"marketCap":15585246612},{"date":"2021-12-17","current":997.497027,"twenty":-144.931156,"median":-82.965863,"eighty":17.854801,"marketCap":15877160172},{"date":"2021-12-23","current":1051.478133,"twenty":-144.931156,"median":-82.965863,"eighty":17.921454,"marketCap":16736377443},{"date":"2021-12-31","current":1019.0664,"twenty":-144.931156,"median":-82.965863,"eighty":18.068316,"marketCap":16220479893},{"date":"2022-01-07","current":971.77526,"twenty":-144.868574,"median":-82.756306,"eighty":18.102568,"marketCap":15467746814},{"date":"2022-01-14","current":1040.635774,"twenty":-144.868574,"median":-82.756306,"eighty":18.18902,"marketCap":16563799615},{"date":"2022-01-21","current":976.38903,"twenty":-144.868574,"median":-82.756306,"eighty":18.272526,"marketCap":15541184188},{"date":"2022-01-28","current":993.806011,"twenty":-144.868574,"median":-82.756306,"eighty":18.302,"marketCap":15818410273},{"date":"2022-02-04","current":1022.296039,"twenty":-144.868574,"median":-82.756306,"eighty":18.385092,"marketCap":16271886055},{"date":"2022-02-11","current":1048.594527,"twenty":-144.868574,"median":-82.756306,"eighty":18.50696,"marketCap":16690479084},{"date":"2022-02-18","current":978.811259,"twenty":-144.868574,"median":-82.756306,"eighty":18.612353,"marketCap":15579738809},{"date":"2022-02-25","current":-223.863547,"twenty":-146.720429,"median":-83.128851,"eighty":18.645295,"marketCap":14345176092},{"date":"2022-03-04","current":-219.184373,"twenty":-148.717362,"median":-83.543308,"eighty":18.645295,"marketCap":14045334603},{"date":"2022-03-11","current":-218.207922,"twenty":-159.853208,"median":-83.818061,"eighty":18.645295,"marketCap":13982763668},{"date":"2022-03-18","current":-234.549105,"twenty":-161.293219,"median":-83.967078,"eighty":18.645295,"marketCap":15029906670},{"date":"2022-03-25","current":-226.938537,"twenty":-162.185225,"median":-84.288399,"eighty":18.645295,"marketCap":14542221441},{"date":"2022-04-01","current":-227.656515,"twenty":-163.361234,"median":-84.633004,"eighty":18.645295,"marketCap":14588229481},{"date":"2022-04-08","current":-246.955768,"twenty":-164.641244,"median":-84.986921,"eighty":18.645295,"marketCap":15824925610},{"date":"2022-04-14","current":-238.225154,"twenty":-165.041247,"median":-85.857746,"eighty":18.645295,"marketCap":15265467837},{"date":"2022-04-22","current":-232.276832,"twenty":-165.973254,"median":-88.12096,"eighty":18.645295,"marketCap":14884299384},{"date":"2022-04-29","current":382.277246,"twenty":-166.445258,"median":-90.308931,"eighty":18.664196,"marketCap":15041462794},{"date":"2022-05-06","current":372.455987,"twenty":-166.445258,"median":-89.349626,"eighty":18.760072,"marketCap":14655025704},{"date":"2022-05-13","current":365.458317,"twenty":-166.445258,"median":-89.349626,"eighty":18.859197,"marketCap":14379688400},{"date":"2022-05-20","current":374.814577,"twenty":-166.445258,"median":-89.349626,"eighty":18.955948,"marketCap":14747829142},{"date":"2022-05-27","current":380.691624,"twenty":-166.445258,"median":-89.349626,"eighty":19.066512,"marketCap":14979073327},{"date":"2022-06-03","current":364.329924,"twenty":-166.445258,"median":-89.349626,"eighty":19.178673,"marketCap":14335289516},{"date":"2022-06-10","current":352.998976,"twenty":-166.445258,"median":-89.349626,"eighty":19.261875,"marketCap":13889450727},{"date":"2022-06-17","current":357.700614,"twenty":-166.445258,"median":-89.349626,"eighty":19.519294,"marketCap":14074446075},{"date":"2022-06-24","current":408.337255,"twenty":-166.509258,"median":-86.272203,"eighty":107.93637,"marketCap":16066845973},{"date":"2022-07-01","current":399.545192,"twenty":-166.509258,"median":-84.809963,"eighty":110.39574,"marketCap":15720904673},{"date":"2022-07-08","current":418.539809,"twenty":-166.509258,"median":-84.754081,"eighty":111.051374,"marketCap":16468285878},{"date":"2022-07-15","current":409.418632,"twenty":-166.509258,"median":-83.152135,"eighty":111.935442,"marketCap":16109394903},{"date":"2022-07-22","current":400.720602,"twenty":-166.509258,"median":-83.077626,"eighty":112.591077,"marketCap":15767153510},{"date":"2022-07-29","current":404.575945,"twenty":-166.509258,"median":-81.708522,"eighty":113.113211,"marketCap":15918849695},{"date":"2022-08-05","current":327.838991,"twenty":-166.509258,"median":-34.536978,"eighty":114.110012,"marketCap":17726254245},{"date":"2022-08-12","current":325.272938,"twenty":-166.509258,"median":-34.536978,"eighty":114.976279,"marketCap":17587507734},{"date":"2022-08-19","current":318.464838,"twenty":-166.509258,"median":-34.536978,"eighty":115.685314,"marketCap":17219393812},{"date":"2022-08-26","current":312.187472,"twenty":-166.509258,"median":-34.536978,"eighty":116.907582,"marketCap":16879976635},{"date":"2022-09-02","current":307.488024,"twenty":-166.509258,"median":-34.536978,"eighty":117.883617,"marketCap":16625877437},{"date":"2022-09-09","current":318.773561,"twenty":-166.509258,"median":-34.536978,"eighty":141.162306,"marketCap":17236086460},{"date":"2022-09-16","current":302.58276,"twenty":-166.509258,"median":-34.536978,"eighty":148.167383,"marketCap":16360649808},{"date":"2022-09-23","current":291.022801,"twenty":-166.509258,"median":-34.536978,"eighty":150.289725,"marketCap":15735602876},{"date":"2022-09-30","current":290.782684,"twenty":-166.509258,"median":-34.536978,"eighty":152.726136,"marketCap":15722619705},{"date":"2022-10-07","current":302.376944,"twenty":-166.509258,"median":-34.536978,"eighty":167.017841,"marketCap":16349521376},{"date":"2022-10-14","current":299.289715,"twenty":-166.509258,"median":-34.536978,"eighty":168.933976,"marketCap":16182594895},{"date":"2022-10-21","current":308.757218,"twenty":-166.509258,"median":-34.536978,"eighty":170.628042,"marketCap":16694502768},{"date":"2022-10-28","current":192.178834,"twenty":-166.509258,"median":-34.536978,"eighty":175.146289,"marketCap":16126110354},{"date":"2022-11-04","current":182.699459,"twenty":-166.509258,"median":-34.536978,"eighty":176.471621,"marketCap":15330676998},{"date":"2022-11-11","current":181.968573,"twenty":-166.509258,"median":-34.536978,"eighty":178.346579,"marketCap":15269346856},{"date":"2022-11-18","current":195.589638,"twenty":-166.509258,"median":-34.536978,"eighty":182.260927,"marketCap":16412317683},{"date":"2022-11-25","current":214.659129,"twenty":-166.509258,"median":-34.536978,"eighty":187.341695,"marketCap":18012476841},{"date":"2022-12-02","current":233.795065,"twenty":-166.509258,"median":-34.536978,"eighty":190.997361,"marketCap":19618211467},{"date":"2022-12-09","current":226.641237,"twenty":-166.509258,"median":-34.536978,"eighty":192.536436,"marketCap":19017919471},{"date":"2022-12-16","current":240.594523,"twenty":-166.509258,"median":-34.14536,"eighty":193.90401,"marketCap":20188767636},{"date":"2022-12-23","current":231.093,"twenty":-166.509258,"median":-33.835795,"eighty":195.798534,"marketCap":19391475791},{"date":"2022-12-30","current":229.210413,"twenty":-166.509258,"median":15.910621,"eighty":196.943179,"marketCap":19233504213},{"date":"2023-01-06","current":240.771708,"twenty":-166.509258,"median":15.99843,"eighty":199.747589,"marketCap":20203635549},{"date":"2023-01-13","current":249.653085,"twenty":-166.509258,"median":16.07919,"eighty":201.466427,"marketCap":20948889698},{"date":"2023-01-20","current":245.289915,"twenty":-166.509258,"median":16.188691,"eighty":202.812136,"marketCap":20582767336},{"date":"2023-01-27","current":259.730459,"twenty":-166.509258,"median":16.239185,"eighty":206.755441,"marketCap":21794502262},{"date":"2023-02-03","current":248.501386,"twenty":-166.509258,"median":16.333756,"eighty":220.240444,"marketCap":20852248263},{"date":"2023-02-10","current":242.432813,"twenty":-166.509258,"median":16.413891,"eighty":226.49506,"marketCap":20343022235},{"date":"2023-02-17","current":239.885785,"twenty":-166.509258,"median":16.442734,"eighty":229.440754,"marketCap":20129295983},{"date":"2023-02-24","current":226.065387,"twenty":-166.509258,"median":16.476957,"eighty":230.229225,"marketCap":18969598754},{"date":"2023-03-03","current":133.346847,"twenty":-166.509258,"median":16.516158,"eighty":230.229225,"marketCap":18876712940},{"date":"2023-03-10","current":119.234744,"twenty":-166.509258,"median":16.567292,"eighty":230.229225,"marketCap":16878989664},{"date":"2023-03-17","current":120.789579,"twenty":-166.509258,"median":16.617476,"eighty":230.229225,"marketCap":17099093629},{"date":"2023-03-24","current":119.564159,"twenty":-166.509258,"median":16.650384,"eighty":230.229225,"marketCap":16925621860},{"date":"2023-03-31","current":128.128926,"twenty":-166.445258,"median":16.685656,"eighty":229.9413,"marketCap":18138058956},{"date":"2023-04-06","current":127.246097,"twenty":-166.445258,"median":16.720301,"eighty":229.9413,"marketCap":18013084670},{"date":"2023-04-14","current":129.578349,"twenty":-166.509258,"median":16.77077,"eighty":230.229225,"marketCap":18343240618},{"date":"2023-04-21","current":127.575511,"twenty":-166.509258,"median":16.817229,"eighty":230.229225,"marketCap":18059716866},{"date":"2023-04-28","current":242.180022,"twenty":-166.509258,"median":16.855933,"eighty":231.407502,"marketCap":17343722249},{"date":"2023-05-05","current":250.17182,"twenty":-166.509258,"median":16.91578,"eighty":235.380867,"marketCap":17916054913},{"date":"2023-05-12","current":250.014562,"twenty":-166.573259,"median":16.941683,"eighty":237.019824,"marketCap":17904792857},{"date":"2023-05-19","current":241.732289,"twenty":-166.637259,"median":16.967171,"eighty":239.8282,"marketCap":17311657880},{"date":"2023-05-26","current":232.558885,"twenty":-166.637259,"median":17.014711,"eighty":240.585664,"marketCap":16654704583},{"date":"2023-05-30","current":231.916747,"twenty":-166.637259,"median":17.029662,"eighty":240.585664,"marketCap":16608717852},{"date":"2023-06-09","current":241.810918,"twenty":-166.73726,"median":17.061278,"eighty":241.008901,"marketCap":17317288908},{"date":"2023-06-16","current":251.194,"twenty":-166.74926,"median":17.112883,"eighty":241.385297,"marketCap":17989258281},{"date":"2023-06-23","current":250.591176,"twenty":-166.76126,"median":17.196104,"eighty":241.856963,"marketCap":17946087064},{"date":"2023-06-30","current":233.08308,"twenty":-166.76126,"median":17.241,"eighty":242.23058,"marketCap":16692244772},{"date":"2023-07-07","current":224.355242,"twenty":-166.76126,"median":17.308262,"eighty":242.23058,"marketCap":16067200635},{"date":"2023-07-14","current":224.643549,"twenty":-166.76126,"median":17.371372,"eighty":242.23058,"marketCap":16087847738},{"date":"2023-07-21","current":229.439928,"twenty":-166.76126,"median":17.48024,"eighty":242.23058,"marketCap":16431340462},{"date":"2023-07-28","current":226.871375,"twenty":-166.76126,"median":17.641098,"eighty":242.23058,"marketCap":16247393539},{"date":"2023-08-04","current":165.119407,"twenty":-166.76126,"median":17.695247,"eighty":242.23058,"marketCap":16510454583},{"date":"2023-08-11","current":171.085084,"twenty":-166.76126,"median":17.746561,"eighty":242.23058,"marketCap":17106968613},{"date":"2023-08-18","current":168.243389,"twenty":-166.76126,"median":17.778035,"eighty":242.23058,"marketCap":16822824706},{"date":"2023-08-25","current":175.281759,"twenty":-166.76126,"median":17.843539,"eighty":242.23058,"marketCap":17526598357},{"date":"2023-09-01","current":171.969585,"twenty":-166.76126,"median":17.901573,"eighty":242.23058,"marketCap":17195410756},{"date":"2023-09-08","current":170.162944,"twenty":-166.76126,"median":18.020515,"eighty":242.23058,"marketCap":17014762974},{"date":"2023-09-15","current":165.006492,"twenty":-166.76126,"median":18.09038,"eighty":242.23058,"marketCap":16499164096},{"date":"2023-09-22","current":162.352988,"twenty":-166.76126,"median":18.138595,"eighty":242.23058,"marketCap":16233837666},{"date":"2023-09-29","current":167.961101,"twenty":-166.76126,"median":18.255988,"eighty":242.23058,"marketCap":16794598490},{"date":"2023-10-06","current":164.272544,"twenty":-166.76126,"median":18.295251,"eighty":242.23058,"marketCap":16425775935},{"date":"2023-10-13","current":162.861106,"twenty":-166.76126,"median":18.372948,"eighty":242.23058,"marketCap":16284644855},{"date":"2023-10-20","current":155.427533,"twenty":-166.76126,"median":18.480739,"eighty":242.23058,"marketCap":15541354502},{"date":"2023-10-27","current":154.260745,"twenty":-166.76126,"median":18.544458,"eighty":242.382255,"marketCap":15424686142},{"date":"2023-11-03","current":102.060294,"twenty":-166.76126,"median":18.649124,"eighty":242.382255,"marketCap":15005006530},{"date":"2023-11-10","current":107.264835,"twenty":-166.76126,"median":18.746862,"eighty":242.382255,"marketCap":15770183276},{"date":"2023-11-17","current":111.736338,"twenty":-166.76126,"median":18.837592,"eighty":242.382255,"marketCap":16427588192},{"date":"2023-11-24","current":112.991947,"twenty":-166.76126,"median":18.922633,"eighty":242.382255,"marketCap":16612189000},{"date":"2023-12-01","current":116.69471,"twenty":-166.76126,"median":18.980092,"eighty":242.382255,"marketCap":17156573014},{"date":"2023-12-08","current":121.64027,"twenty":-166.76126,"median":19.115548,"eighty":242.331697,"marketCap":17883674154},{"date":"2023-12-15","current":125.073975,"twenty":-166.76126,"median":19.224871,"eighty":242.331697,"marketCap":18388500853},{"date":"2023-12-22","current":121.922141,"twenty":-166.76126,"median":19.421383,"eighty":242.331697,"marketCap":17925115152},{"date":"2023-12-29","current":124.446171,"twenty":-166.76126,"median":97.655587,"eighty":242.382255,"marketCap":18296200449},{"date":"2024-01-05","current":125.21491,"twenty":-166.76126,"median":106.724665,"eighty":242.432813,"marketCap":18409221351},{"date":"2024-01-12","current":122.998377,"twenty":-166.76126,"median":107.662485,"eighty":242.432813,"marketCap":18083344416},{"date":"2024-01-19","current":118.552498,"twenty":-166.79726,"median":109.532617,"eighty":242.575773,"marketCap":17429706862},{"date":"2024-01-26","current":116.91252,"twenty":-166.76126,"median":110.397223,"eighty":242.432813,"marketCap":17188595603},{"date":"2024-02-02","current":113.696625,"twenty":-166.76126,"median":111.153724,"eighty":242.432813,"marketCap":16715791494},{"date":"2024-02-09","current":112.940697,"twenty":-166.76126,"median":111.821225,"eighty":242.432813,"marketCap":16604654273},{"date":"2024-02-16","current":113.132882,"twenty":-166.76126,"median":112.099749,"eighty":242.432813,"marketCap":16632909499},{"date":"2024-02-23","current":101.214924,"twenty":-166.70126,"median":112.294622,"eighty":242.432813,"marketCap":16968175915},{"date":"2024-03-01","current":97.103598,"twenty":-165.901253,"median":112.199476,"eighty":242.382255,"marketCap":16278932666},{"date":"2024-03-08","current":96.664673,"twenty":-164.837246,"median":112.199476,"eighty":242.382255,"marketCap":16205349173},{"date":"2024-03-15","current":94.976502,"twenty":-164.11324,"median":112.199476,"eighty":242.382255,"marketCap":15922335740},{"date":"2024-03-22","current":94.661377,"twenty":-162.221226,"median":112.199476,"eighty":242.382255,"marketCap":15869506566},{"date":"2024-03-28","current":99.72589,"twenty":-162.081225,"median":112.199476,"eighty":242.382255,"marketCap":16718546865},{"date":"2024-04-05","current":97.790121,"twenty":-160.981216,"median":112.294622,"eighty":242.432813,"marketCap":16394024795},{"date":"2024-04-12","current":103.533211,"twenty":-131.648601,"median":112.294622,"eighty":242.432813,"marketCap":17356825158},{"date":"2024-04-19","current":101.959724,"twenty":-125.404689,"median":112.294622,"eighty":242.432813,"marketCap":17093037852},{"date":"2024-04-26","current":75.899547,"twenty":-124.450186,"median":112.199476,"eighty":242.382255,"marketCap":15593941332},{"date":"2024-05-03","current":77.447263,"twenty":-123.068927,"median":112.199476,"eighty":242.382255,"marketCap":15911927491},{"date":"2024-05-10","current":75.524945,"twenty":-121.619256,"median":112.199476,"eighty":242.382255,"marketCap":15516977501},{"date":"2024-05-17","current":71.135034,"twenty":-119.850332,"median":112.199476,"eighty":242.382255,"marketCap":14615048436},{"date":"2024-05-24","current":70.146149,"twenty":-118.560287,"median":112.199476,"eighty":242.382255,"marketCap":14411877047},{"date":"2024-05-31","current":68.833797,"twenty":-117.48525,"median":112.199476,"eighty":242.382255,"marketCap":14142247727},{"date":"2024-06-07","current":74.720898,"twenty":-116.644766,"median":112.199476,"eighty":242.382255,"marketCap":15351782072},{"date":"2024-06-14","current":77.853908,"twenty":-111.266324,"median":112.294622,"eighty":242.432813,"marketCap":15995474604},{"date":"2024-06-21","current":78.288278,"twenty":-109.731954,"median":112.389767,"eighty":242.575773,"marketCap":16084718112},{"date":"2024-06-28","current":77.170006,"twenty":-106.985723,"median":112.453746,"eighty":243.004654,"marketCap":15854963550},{"date":"2024-07-05","current":74.836422,"twenty":-105.324301,"median":112.453746,"eighty":243.004654,"marketCap":15375517047},{"date":"2024-07-12","current":77.548924,"twenty":15.962481,"median":112.453746,"eighty":243.004654,"marketCap":15932814269},{"date":"2024-07-15","current":78.574777,"twenty":15.978924,"median":112.453746,"eighty":243.004654,"marketCap":16143580851},{"date":"2024-08-02","current":78.205101,"twenty":16.215911,"median":112.851011,"eighty":244.594819,"marketCap":16067628929},{"date":"2024-08-09","current":65.219671,"twenty":16.277249,"median":112.851011,"eighty":244.594819,"marketCap":16734650053},{"date":"2024-08-16","current":66.1694,"twenty":16.362887,"median":112.851011,"eighty":244.594819,"marketCap":16978340065},{"date":"2024-08-23","current":66.792659,"twenty":16.42422,"median":112.851011,"eighty":244.594819,"marketCap":17138261636},{"date":"2024-08-30","current":67.794327,"twenty":16.45237,"median":112.851011,"eighty":244.594819,"marketCap":17395278446},{"date":"2024-09-06","current":63.156978,"twenty":16.479702,"median":112.851011,"eighty":244.594819,"marketCap":16205385808},{"date":"2024-09-13","current":62.607916,"twenty":16.537344,"median":112.851011,"eighty":244.594819,"marketCap":16064502520},{"date":"2024-09-20","current":52.98449,"twenty":16.577992,"median":112.851011,"eighty":244.594819,"marketCap":13595237319},{"date":"2024-09-27","current":52.116378,"twenty":16.619251,"median":112.851011,"eighty":244.594819,"marketCap":13372489417},{"date":"2024-10-04","current":50.573069,"twenty":16.6558,"median":112.851011,"eighty":244.594819,"marketCap":12976493147},{"date":"2024-10-11","current":51.827008,"twenty":16.697708,"median":112.851011,"eighty":244.594819,"marketCap":13298240116},{"date":"2024-10-18","current":51.545057,"twenty":16.760117,"median":112.851011,"eighty":244.594819,"marketCap":13225894644},{"date":"2024-10-25","current":52.227675,"twenty":16.799788,"median":112.851011,"eighty":244.594819,"marketCap":13401046840},{"date":"2024-10-31","current":39.424418,"twenty":16.832825,"median":112.851011,"eighty":244.594819,"marketCap":12706135252},{"date":"2024-11-08","current":39.584187,"twenty":16.900012,"median":112.851577,"eighty":244.597655,"marketCap":12757627091},{"date":"2024-11-15","current":38.791793,"twenty":16.930391,"median":112.851577,"eighty":244.597655,"marketCap":12502245849},{"date":"2024-11-22","current":37.520416,"twenty":16.956385,"median":112.851577,"eighty":244.597655,"marketCap":12092492365},{"date":"2024-11-29","current":39.046069,"twenty":16.983395,"median":112.851577,"eighty":244.597655,"marketCap":12584196546},{"date":"2024-12-06","current":39.122943,"twenty":17.042364,"median":112.851577,"eighty":244.597655,"marketCap":12608972338},{"date":"2024-12-13","current":39.182077,"twenty":17.063524,"median":112.851577,"eighty":244.597655,"marketCap":12628030640},{"date":"2024-12-20","current":38.43699,"twenty":17.120949,"median":112.851577,"eighty":244.597655,"marketCap":12387896040},{"date":"2024-12-27","current":39.631494,"twenty":17.201205,"median":112.851577,"eighty":244.597655,"marketCap":12772873732},{"date":"2025-01-03","current":39.318084,"twenty":17.236838,"median":112.851577,"eighty":244.597655,"marketCap":12671864733},{"date":"2025-01-10","current":40.435714,"twenty":17.313842,"median":112.852143,"eighty":244.60049,"marketCap":13032066634},{"date":"2025-01-17","current":36.219472,"twenty":17.376382,"median":112.852143,"eighty":244.60049,"marketCap":11673209730},{"date":"2025-01-24","current":36.77533,"twenty":17.466817,"median":112.852143,"eighty":244.60049,"marketCap":11852357765},{"date":"2025-01-31","current":37.774691,"twenty":17.638541,"median":112.852143,"eighty":244.60049,"marketCap":12174443062},{"date":"2025-02-07","current":38.046707,"twenty":17.688324,"median":112.852143,"eighty":244.60049,"marketCap":12262111249},{"date":"2025-02-14","current":38.094014,"twenty":17.743365,"median":112.852143,"eighty":244.60049,"marketCap":12277357890},{"date":"2025-02-21","current":30.715125,"twenty":17.776197,"median":112.852143,"eighty":244.60049,"marketCap":13111027516},{"date":"2025-02-28","current":30.891957,"twenty":17.826301,"median":112.852143,"eighty":244.60049,"marketCap":13186509834},{"date":"2025-03-07","current":31.826045,"twenty":17.900998,"median":112.870795,"eighty":244.603325,"marketCap":13585233872},{"date":"2025-03-14","current":31.553417,"twenty":18.033156,"median":112.870795,"eighty":244.603325,"marketCap":13468859871},{"date":"2025-03-21","current":32.000349,"twenty":18.097039,"median":112.870795,"eighty":244.603325,"marketCap":13659636923},{"date":"2025-03-28","current":32.550076,"twenty":18.156695,"median":112.870795,"eighty":244.603325,"marketCap":13894292697},{"date":"2025-04-04","current":30.158988,"twenty":18.272189,"median":112.870795,"eighty":244.603325,"marketCap":12873635468},{"date":"2025-04-11","current":25.171224,"twenty":18.291457,"median":112.852143,"eighty":244.60049,"marketCap":10744563568},{"date":"2025-04-17","current":26.423199,"twenty":18.323094,"median":112.852143,"eighty":244.60049,"marketCap":11278980279},{"date":"2025-04-25","current":28.184147,"twenty":18.45537,"median":112.870795,"eighty":244.603325,"marketCap":12030656625},{"date":"2025-05-01","current":28.610907,"twenty":18.510369,"median":112.838199,"eighty":244.603325,"marketCap":12212823087}],"updateTime":1746230425073}}}